Table 1 Clinical and pathologic characteristics for 88 patients with malignant prostate cancer
From: MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
Variable: | Median (range) or NO. of patient |
|---|---|
Age: | 71 years (55–92) |
Preoperative PSA: | 77.56 ng/ml (0.2–100.00) |
Follow-up: | 51 months (3–111) |
Gleason score: | Â |
<7 | 27 |
7 | 41 |
>7 | 20 |
TNM staging: | Â |
pT2 | 67 |
pT3-pT4 | 21 |